X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1658) 1658
Publication (230) 230
Book Review (120) 120
Newsletter (8) 8
Newspaper Article (6) 6
Magazine Article (5) 5
Book Chapter (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1624) 1624
index medicus (1561) 1561
middle aged (1387) 1387
female (1385) 1385
male (1288) 1288
adult (1087) 1087
aged (956) 956
adolescent (405) 405
young adult (357) 357
aged, 80 and over (355) 355
research (319) 319
risk factors (307) 307
health aspects (230) 230
research article (207) 207
treatment outcome (186) 186
care and treatment (183) 183
analysis (178) 178
studies (176) 176
prevalence (171) 171
article (166) 166
abridged index medicus (162) 162
cross-sectional studies (160) 160
surgery (159) 159
medicine & public health (158) 158
retrospective studies (157) 157
public, environmental & occupational health (153) 153
surveys and questionnaires (149) 149
oncology (146) 146
cancer (143) 143
follow-up studies (141) 141
diagnosis (140) 140
prospective studies (127) 127
medicine (124) 124
time factors (122) 122
child (119) 119
risk (118) 118
epidemiology (117) 117
mortality (115) 115
disease (114) 114
prognosis (113) 113
patients (111) 111
women (108) 108
usage (103) 103
medical research (101) 101
population (95) 95
age factors (94) 94
public health (94) 94
health (92) 92
prevention (89) 89
adults (87) 87
medicine, general & internal (84) 84
immunology (83) 83
neurosciences (83) 83
age (80) 80
infection (80) 80
quality of life (78) 78
aged 16-26 years (77) 77
management (77) 77
nursing (77) 77
psychiatry (77) 77
cardiac & cardiovascular systems (76) 76
incidence (75) 75
clinical neurology (74) 74
infectious diseases (74) 74
sex factors (72) 72
socioeconomic factors (72) 72
cohort studies (71) 71
obesity (71) 71
case-control studies (69) 69
impact (66) 66
risk-factors (66) 66
medicine, experimental (65) 65
reproducibility of results (65) 65
particle vaccine (64) 64
united-states (64) 64
child, preschool (62) 62
papillomavirus infections - prevention & control (62) 62
metaanalysis (61) 61
cervical cancer (60) 60
orthopedics (60) 60
physiological aspects (60) 60
follow-up (59) 59
human papillomavirus (59) 59
multidisciplinary sciences (59) 59
science (59) 59
cardiovascular disease (58) 58
diabetes (58) 58
patient outcomes (58) 58
body mass index (57) 57
hospitals (57) 57
risk assessment (57) 57
medicine, research & experimental (56) 56
multivariate analysis (56) 56
original (56) 56
regression analysis (56) 56
drug therapy (55) 55
rehabilitation (55) 55
care (54) 54
genetic aspects (54) 54
infections (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1668) 1668
Italian (2) 2
Lithuanian (2) 2
Spanish (2) 2
German (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2015, Volume 372, Issue 8, pp. 711 - 723
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2011, Volume 364, Issue 5, pp. 401 - 411
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9686, pp. 301 - 314
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2010, Volume 102, Issue 5, pp. 325 - 339
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital... 
AGED 16-26 YEARS | QUADRIVALENT VACCINE | ONCOLOGY | NEUTRALIZING EPITOPES | CLINICAL-TRIALS | DOUBLE-BLIND | TYPE-18 | VIRUS-LIKE PARTICLES | PROPHYLACTIC EFFICACY | RANDOMIZED CONTROLLED-TRIAL | CERVICAL INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Tumor Virus Infections - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Genital Diseases, Female - prevention & control | Sexually Transmitted Diseases - epidemiology | Alphapapillomavirus - immunology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Young Adult | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 11 - immunology | Tumor Virus Infections - epidemiology | Papillomavirus Vaccines - administration & dosage | Genital Diseases, Female - virology | Papillomavirus Infections - complications | Global Health | Papanicolaou Test | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Kaplan-Meier Estimate | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomavirus Vaccines - pharmacology | Tumor Virus Infections - prevention & control | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Sexual Partners | Prevention | Complications and side effects | Care and treatment | Young women | Research | Health aspects | Papillomavirus infections | Risk factors | Genital diseases, Female | Women | Studies | Human papillomavirus | Immunization | Teenagers | Vaccines | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 09/2018, Volume 11, Issue 9, pp. 581 - 591
In 2012, Colombia launched human papillomavirus (HPV) vaccination program for girls ages 9 to 12, and in 2013, the target age was expanded to 9 to 17 years.... 
UNITED-STATES | AGED 16-26 YEARS | RISK-FACTORS | ONCOLOGY | HUMAN-PAPILLOMAVIRUS HPV | PARTICLE VACCINE | MULTIPLE TYPES | DOUBLE-BLIND | CERVICAL-CANCER | PREVALENCE | HPV-16/18 AS04-ADJUVANTED VACCINE
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 11, pp. 1314 - 1323
Journal Article